603387 基蛋生物
午间休市 12-24 11:29:53
资讯
新帖
简况
每周股票复盘：基蛋生物（603387）海外常规产品收入增46.21%
证券之星 · 11-23
每周股票复盘：基蛋生物（603387）海外常规产品收入增46.21%
基蛋生物（603387）披露2025年第三季度业绩网上说明会召开情况，11月21日股价下跌3.8%
证券之星 · 11-21
基蛋生物（603387）披露2025年第三季度业绩网上说明会召开情况，11月21日股价下跌3.8%
基蛋生物信披评级两年下降两级，从A优秀降低至C合格
新浪证券 · 11-07
基蛋生物信披评级两年下降两级，从A优秀降低至C合格
每周股票复盘：基蛋生物（603387）Q3净利同比增80.83%
证券之星 · 11-02
每周股票复盘：基蛋生物（603387）Q3净利同比增80.83%
图解基蛋生物三季报：第三季度单季净利润同比增长80.83%
证券之星 · 10-30
图解基蛋生物三季报：第三季度单季净利润同比增长80.83%
基蛋生物（603387）披露关于完成工商变更登记及备案并取得营业执照的公告，9月29日股价上涨0.38%
证券之星 · 09-29
基蛋生物（603387）披露关于完成工商变更登记及备案并取得营业执照的公告，9月29日股价上涨0.38%
每周股票复盘：基蛋生物（603387）取消监事会并完成董事会重组
证券之星 · 09-21
每周股票复盘：基蛋生物（603387）取消监事会并完成董事会重组
基蛋生物（603387）披露公司涉及诉讼的进展公告，9月18日股价下跌1.43%
证券之星 · 09-18
基蛋生物（603387）披露公司涉及诉讼的进展公告，9月18日股价下跌1.43%
每周股票复盘：基蛋生物（603387）拟每10股派0.9元
证券之星 · 09-14
每周股票复盘：基蛋生物（603387）拟每10股派0.9元
每周股票复盘：基蛋生物（603387）半年报净利降25.88%
证券之星 · 08-31
每周股票复盘：基蛋生物（603387）半年报净利降25.88%
基蛋生物（603387）2025年中报简析：净利润同比下降25.88%，公司应收账款体量较大
证券之星 · 08-31
基蛋生物（603387）2025年中报简析：净利润同比下降25.88%，公司应收账款体量较大
图解基蛋生物中报：第二季度单季净利润同比下降26.80%
证券之星 · 08-30
图解基蛋生物中报：第二季度单季净利润同比下降26.80%
每周股票复盘：基蛋生物（603387）涉及诉讼终审胜诉及股东减持完成
证券之星 · 08-17
每周股票复盘：基蛋生物（603387）涉及诉讼终审胜诉及股东减持完成
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
病毒检测概念盘中跳水，丽珠集团跌0.47%
市场透视 · 08-08
病毒检测概念盘中跳水，丽珠集团跌0.47%
宠物产业升级加速 市场步入黄金发展期
第一财经 · 08-06
宠物产业升级加速 市场步入黄金发展期
每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段
证券之星 · 07-27
每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段
多家跨国医疗巨头奔赴链博会，本土药械供应链再升级
第一财经 · 07-16
多家跨国医疗巨头奔赴链博会，本土药械供应链再升级
每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段
证券之星 · 07-13
每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段
基蛋生物与控股子公司景川诊断股份转让纠纷二审立案
财中社 · 07-08
基蛋生物与控股子公司景川诊断股份转让纠纷二审立案
加载更多
公司概况
公司名称：
基蛋生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-17
主营业务：
基蛋生物科技股份有限公司的主营业务是体外诊断试剂与仪器的研发、生产、销售及服务。公司的主要产品是POCT试剂、发光试剂、生化、血球试剂、POCT、发光、血球仪器。截至2025年6月30日，公司授权专利合计383件，其中，授权发明专利57件，实用新型专利296件，外观专利30件。
发行价格：
22.25
{"stockData":{"symbol":"603387","market":"SH","secType":"STK","nameCN":"基蛋生物","latestPrice":8.27,"timestamp":1766546993000,"preClose":8.26,"halted":0,"volume":1984212,"delay":0,"changeRate":0.0012,"floatShares":507000000,"shares":507000000,"eps":0.4117,"marketStatus":"午间休市","change":0.01,"latestTime":"12-24 11:29:53","open":8.28,"high":8.28,"low":8.21,"amount":16385300,"amplitude":0.0085,"askPrice":8.28,"askSize":129,"bidPrice":8.27,"bidSize":95,"shortable":0,"etf":0,"ttmEps":0.4117,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766552400000},"marketStatusCode":3,"adr":0,"adjPreClose":8.26,"symbolType":"stock","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":9.09,"lowLimit":7.43,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":507153517,"isCdr":false,"pbRate":1.56,"roa":"--","peRate":20.087442,"roe":"6.0%","epsLYR":0.44,"committee":0.244592,"marketValue":4194000000,"turnoverRate":0.0039,"status":0,"floatMarketCap":4194000000},"requestUrl":"/m/hq/s/603387","defaultTab":"news","newsList":[{"id":"2585105810","title":"每周股票复盘：基蛋生物（603387）海外常规产品收入增46.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105810","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105810?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:18","pubTimestamp":1763839094,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，基蛋生物报收于8.1元，较上周的8.75元下跌7.43%。本周，基蛋生物11月17日盘中最高价报8.76元。基蛋生物当前最新总市值41.08亿元，在医疗器械板块市值排名81/126，在两市A股市值排名3737/5167。公司海外常规产品收入同比增长46.21%，Metis6000流水线前三季度装机进展顺利，化学发光试剂检测量同比增长超30%，期间费用同比下降11.47%。同时回应了投资者关于流感季检测产品、套餐拆解政策影响等问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0239","603387"],"gpt_icon":0},{"id":"2585149006","title":"基蛋生物（603387）披露2025年第三季度业绩网上说明会召开情况，11月21日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585149006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585149006?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:34","pubTimestamp":1763735668,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，基蛋生物报收于8.1元，较前一交易日下跌3.8%，最新总市值为41.08亿元。该股当日开盘8.42元，最高8.43元，最低8.1元，成交额达7104.2万元，换手率为1.71%。公司近日发布公告称，已于2025年11月21日召开2025年第三季度业绩网上说明会，公司董事长、财务总监、董事会秘书及独立董事出席。公司海外常规产品收入同比增长46.21%，Metis6000流水线前三季度装机进展顺利，化学发光试剂检测量同比增长超30%，期间费用同比下降11.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","603387","BK0046"],"gpt_icon":0},{"id":"2581005252","title":"基蛋生物信披评级两年下降两级，从A优秀降低至C合格","url":"https://stock-news.laohu8.com/highlight/detail?id=2581005252","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581005252?lang=zh_cn&edition=full","pubTime":"2025-11-07 18:06","pubTimestamp":1762509960,"startTime":"0","endTime":"0","summary":" 近日，交易所披露上市公司2024年信息披露工作评价结果。数据显示，2024年信披考评结果相较于2022年，基蛋生物信披评级下降两级，从A降低至C。 choice数据显示，基蛋生物现任董秘为刘葱，于2020-12-18上任。资料显示，刘葱女士，中国国籍，无境外永久居留权，1986年4月生，硕士学历。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-11-07/doc-infwqrfw6012910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603387"],"gpt_icon":0},{"id":"2580891477","title":"每周股票复盘：基蛋生物（603387）Q3净利同比增80.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580891477","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580891477?lang=zh_cn&edition=full","pubTime":"2025-11-02 07:06","pubTimestamp":1762038376,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，基蛋生物报收于8.33元，较上周的8.13元上涨2.46%。本周，基蛋生物10月31日盘中最高价报8.35元。业绩披露要点财务报告基蛋生物2025年三季报显示，前三季度主营收入7.58亿元，同比下降13.88%；归母净利润1.61亿元，同比下降8.48%；扣非净利润1.35亿元，同比下降9.96%。2025年第三季度单季度主营收入2.45亿元，同比下降6.55%；单季度归母净利润5173.5万元，同比上升80.83%；单季度扣非净利润4130.3万元，同比上升117.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0239","603387"],"gpt_icon":0},{"id":"2579814976","title":"图解基蛋生物三季报：第三季度单季净利润同比增长80.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579814976","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579814976?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:22","pubTimestamp":1761826953,"startTime":"0","endTime":"0","summary":"证券之星消息，基蛋生物2025年三季报显示，前三季度公司主营收入7.58亿元，同比下降13.88%；归母净利润1.61亿元，同比下降8.48%；扣非净利润1.35亿元，同比下降9.96%；其中2025年第三季度，公司单季度主营收入2.45亿元，同比下降6.55%；单季度归母净利润5173.5万元，同比上升80.83%；单季度扣非净利润4130.3万元，同比上升117.52%；负债率26.98%，投资收益711.06万元，财务费用-1384.95万元，毛利率68.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000041021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603387"],"gpt_icon":0},{"id":"2571337584","title":"基蛋生物（603387）披露关于完成工商变更登记及备案并取得营业执照的公告，9月29日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571337584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571337584?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:34","pubTimestamp":1759156460,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，基蛋生物报收于8.03元，较前一交易日上涨0.38%，最新总市值为40.72亿元。该股当日开盘8.0元，最高8.03元，最低7.85元，成交额达4202.13万元，换手率为1.04%。近日，基蛋生物科技股份有限公司发布公告称，公司已完成工商变更登记及备案手续，并取得南京市市场监督管理局换发的《营业执照》。此次变更涉及公司治理结构的调整，包括取消监事会及修订《公司章程》等相关事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0239","603387"],"gpt_icon":0},{"id":"2569246224","title":"每周股票复盘：基蛋生物（603387）取消监事会并完成董事会重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246224","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246224?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:47","pubTimestamp":1758401231,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，基蛋生物报收于8.22元，较上周的8.49元下跌3.18%。本周关注点公司公告汇总：基蛋生物取消监事会，修订公司章程，完成治理结构重大调整。会议审议通过《关于取消监事会并修订〈公司章程〉的议案》及相关议事规则修订案，所有议案均获通过。同日，公司召开职工代表大会，选举总经理助理李靖女士为第四届董事会职工代表董事，任期至本届董事会届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0042","603387"],"gpt_icon":0},{"id":"2568096384","title":"基蛋生物（603387）披露公司涉及诉讼的进展公告，9月18日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568096384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568096384?lang=zh_cn&edition=full","pubTime":"2025-09-18 23:04","pubTimestamp":1758207858,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘，基蛋生物报收于8.27元，较前一交易日下跌1.43%，最新总市值为41.94亿元。该股当日开盘8.4元，最高8.41元，最低8.23元，成交额达5548.11万元，换手率为1.31%。近日，基蛋生物科技股份有限公司发布关于公司涉及诉讼的进展公告。原告武汉众聚成咨询管理有限责任公司诉称公司与武汉景川诊断技术股份有限公司存在同业竞争，请求确认同业竞争行为、公开道歉、赔偿损失等。一审法院已驳回原告全部诉讼请求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800037963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603387","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2567013996","title":"每周股票复盘：基蛋生物（603387）拟每10股派0.9元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567013996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567013996?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:58","pubTimestamp":1757800695,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，基蛋生物报收于8.49元，较上周的8.42元上涨0.83%。本周，基蛋生物9月9日盘中最高价报8.57元。公司公告汇总基蛋生物科技股份有限公司2025年半年度权益分派实施公告：每股现金红利0.09元（含税），分配对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。本次利润分配以总股本507,153,517股为基数，共计派发现金红利45,643,816.53元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","603387","BK0046"],"gpt_icon":0},{"id":"2563836540","title":"每周股票复盘：基蛋生物（603387）半年报净利降25.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563836540","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563836540?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:10","pubTimestamp":1756606219,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，基蛋生物报收于8.48元，较上周的8.83元下跌3.96%。本周关注点业绩披露要点：基蛋生物2025年中报归母净利润同比下降25.88%。股本股东变化截至2025年6月30日，基蛋生物股东户数为26,294户，较3月31日减少453户，减幅1.69%。第二季度单季营收2.69亿元，同比降9.3%；归母净利润4450.13万元，同比降26.8%。公司公告汇总基蛋生物拟向全体股东每10股派发现金红利0.9元（含税），以2025年8月28日总股本507,153,517股计算，合计派发45,643,816.53元，占半年度归母净利润的41.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603387","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2563809758","title":"基蛋生物（603387）2025年中报简析：净利润同比下降25.88%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2563809758","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563809758?lang=zh_cn&edition=full","pubTime":"2025-08-31 06:11","pubTimestamp":1756591903,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期基蛋生物发布2025年中报。截至本报告期末，公司营业总收入5.13亿元，同比下降17.0%，归母净利润1.09亿元，同比下降25.88%。按单季度数据看，第二季度营业总收入2.69亿元，同比下降9.3%，第二季度归母净利润4450.13万元，同比下降26.8%。本报告期基蛋生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达177.8%。筹资活动产生的现金流量净额变动幅度为155.79%,原因:公司借款收到的现金增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100001414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603387"],"gpt_icon":0},{"id":"2563907633","title":"图解基蛋生物中报：第二季度单季净利润同比下降26.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563907633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563907633?lang=zh_cn&edition=full","pubTime":"2025-08-30 02:03","pubTimestamp":1756490612,"startTime":"0","endTime":"0","summary":"证券之星消息，基蛋生物2025年中报显示，公司主营收入5.13亿元，同比下降17.0%；归母净利润1.09亿元，同比下降25.88%；扣非净利润9322.86万元，同比下降28.52%；其中2025年第二季度，公司单季度主营收入2.69亿元，同比下降9.3%；单季度归母净利润4450.13万元，同比下降26.8%；单季度扣非净利润3271.51万元，同比下降31.41%；负债率28.43%，投资收益154.52万元，财务费用-1099.18万元，毛利率69.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000005418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603387"],"gpt_icon":0},{"id":"2560926693","title":"每周股票复盘：基蛋生物（603387）涉及诉讼终审胜诉及股东减持完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926693?lang=zh_cn&edition=full","pubTime":"2025-08-17 05:50","pubTimestamp":1755381025,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，基蛋生物报收于8.76元，较上周的8.75元上涨0.11%。本周关注点公司公告汇总：基蛋生物涉及诉讼终审胜诉，维持原判，不涉及具体诉讼金额。景川诊断不服一审判决，向武汉市中级人民法院提起上诉，请求撤销一审判决并驳回基蛋生物的诉讼请求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603387","BK0042","BK0046"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600645","688351","688580","688085","688389","159883","603309","688050","688613","688026","688016","688298","688617","688607","688575","688161","603222","688271","688217","688606","688277","688314","600587","688212","688755","688581","688273","560260","603205","688426","688338","603976","688108","688289","688114","688468","688317","688193","688253","688067","600055","603987","688410","603880","688068","688576","688013","600529","688139","688198","603014","605369","688151","688767","603658","688301","688358","688393","688677","600807","688366","688029","688656","688236","688075","603387"],"gpt_icon":0},{"id":"2557515952","title":"病毒检测概念盘中跳水，丽珠集团跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515952?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:47","pubTimestamp":1754617635,"startTime":"0","endTime":"0","summary":"08月08日，病毒检测概念盘中跳水，截至09点47分，病毒检测概念整体指数下跌1.12%，报1104.840点。从个股上来看，该概念的成分股中，丽珠集团跌0.47%，基蛋生物、硕世生物、上海莱士跌幅居前。从资金上来看，截止发稿，病毒检测概念主力净流入为-3.59亿，其中乐普医疗受到资金热捧，主力净流入7706.49万；拉长时间线来看，该板块近20日主力资金净流入-40.24亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094715a6d9db79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094715a6d9db79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603387","BK0046","BK0028","000513","BK0042","BK0187","688399","BK0188"],"gpt_icon":0},{"id":"2557100673","title":"宠物产业升级加速 市场步入黄金发展期","url":"https://stock-news.laohu8.com/highlight/detail?id=2557100673","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557100673?lang=zh_cn&edition=full","pubTime":"2025-08-06 07:34","pubTimestamp":1754436881,"startTime":"0","endTime":"0","summary":"据中证报，宠物经济浪潮下，国内宠物食品龙头中宠股份于8月5日晚披露2025年半年报。公告显示，中宠股份业绩延续高增长态势，主粮业务爆发式增长与全球化产能布局成为核心驱动力。“随着年轻群体养宠渗透率提升和消费升级，宠物行业正从基础用品向主粮、健康服务等高端领域延伸，产业链上市公司集体受益。”业内人士表示，宠物经济已步入黄金发展期，但竞争加剧亦推动行业加速分化——产品研发、供应链整合与全渠道运营能力将成为企业突围关键。龙头公司凭借技术壁垒和全球化资源整合优势，有望在千亿赛道中持续领跑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080607344197363b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080607344197363b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603955","605338","603566","603182","600539","688089","605507","BK0028","BK0239","603102","605009","BK0060","600195","688526","603238","600201","BK0188","600267","600826","603739","159831","603609","688621","603387","600655","688298","603538"],"gpt_icon":0},{"id":"2554714962","title":"每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2554714962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554714962?lang=zh_cn&edition=full","pubTime":"2025-07-27 04:45","pubTimestamp":1753562709,"startTime":"0","endTime":"0","summary":"截至2025年7月25日收盘，基蛋生物报收于8.71元，较上周的8.41元上涨3.57%。本周关注点公司公告汇总：基蛋生物涉及诉讼进展至二审阶段，涉案金额暂无法判断对公司利润影响公司公告汇总基蛋生物科技股份有限公司发布关于公司涉及诉讼的进展公告。一审判决于2025年4月作出，武汉东湖新技术开发区人民法院驳回武汉众聚成的诉讼请求。公司将根据诉讼进展情况及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072700000849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0239","603387"],"gpt_icon":0},{"id":"2551662190","title":"多家跨国医疗巨头奔赴链博会，本土药械供应链再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551662190","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551662190?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596100,"startTime":"0","endTime":"0","summary":"第一财经记者获悉，即将于7月16日开幕的第三届中国国际供应链促进博览会，包括美敦力、阿斯利康、GE医疗等跨国医疗巨头确认参展。美敦力方面介绍，今年是该公司首次参加链博会，并将展示一款全新的由美敦力中国研发中心和本土临床专家合作的起搏心脏导管研发成果。在本届链博会上，阿斯利康国际市场供应链管理高级执行总裁Steven Rota也将发表主旨演讲。阿斯利康已连续第三年参加链博会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603014","603309","688193","159891","688314","688399","688581","688767","688212","688606","600587","688393","688067","688317","688607","688358","603976","688289","BK0239","688298","688068","688271","688075","688613","688656","603205","688085","600807","688366","688029","688151","688139","688050","603658","688273","688410","688301","603387","600529","688016","688426","688617","688236","600055","688161","688626","688013","688026","688114","688217","688338","688468","688677","688575","688198","688253","688389","600645","603301","688576","688351","605369","603222","688755","603987","688580","603880","688108"],"gpt_icon":0},{"id":"2551914621","title":"每周股票复盘：基蛋生物（603387）涉及诉讼进展至二审阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914621?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:42","pubTimestamp":1752360133,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，基蛋生物报收于8.19元，较上周的8.07元上涨1.49%。本周关注点公司公告汇总：基蛋生物涉及诉讼进展至二审阶段，案件处于二审，暂时无法判断对公司利润的影响。公司公告汇总基蛋生物科技股份有限公司发布关于公司涉及诉讼的进展公告。二审情况为景川诊断不服一审判决，向武汉市中级人民法院提起上诉，请求撤销一审判决并驳回原告诉讼请求，诉讼费用由被上诉人承担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0239","603387"],"gpt_icon":0},{"id":"2549294548","title":"基蛋生物与控股子公司景川诊断股份转让纠纷二审立案","url":"https://stock-news.laohu8.com/highlight/detail?id=2549294548","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549294548?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:20","pubTimestamp":1751966409,"startTime":"0","endTime":"0","summary":"7月8日，基蛋生物发布公告，涉及与控股子公司景川诊断的股份转让纠纷诉讼。该案件目前处于二审阶段，公司为被上诉人，尚未确定具体的诉讼金额。由于案件尚未开庭，且没有产生有效判决，因此目前无法判断对公司的利润影响。景川诊断对此判决不服，已向武汉市中级人民法院提起上诉，要求撤销一审判决并驳回基蛋生物的诉讼请求。公司于近日收到武汉市中级人民法院下发的立案受理通知。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708172057979e2466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708172057979e2466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603387","BK0239","BK0042","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766549714557,"stockEarnings":[{"period":"1week","weight":0.0248},{"period":"1month","weight":0.0198},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.0222},{"period":"ytd","weight":0.0234}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1367},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.1695}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"基蛋生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25185人(较上一季度减少4.22%)","perCapita":"20137股","listingDate":"2017-07-17","address":"江苏省南京市六合区沿江工业开发区博富路9号","registeredCapital":"50715万元","survey":" 基蛋生物科技股份有限公司的主营业务是体外诊断试剂与仪器的研发、生产、销售及服务。公司的主要产品是POCT试剂、发光试剂、生化、血球试剂、POCT、发光、血球仪器。截至2025年6月30日，公司授权专利合计383件，其中，授权发明专利57件，实用新型专利296件，外观专利30件。","listedPrice":22.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基蛋生物(603387)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基蛋生物(603387)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基蛋生物,603387,基蛋生物股票,基蛋生物股票老虎,基蛋生物股票老虎国际,基蛋生物行情,基蛋生物股票行情,基蛋生物股价,基蛋生物股市,基蛋生物股票价格,基蛋生物股票交易,基蛋生物股票购买,基蛋生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基蛋生物(603387)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基蛋生物(603387)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}